ClinicalTrials.Veeva

Menu

S-33 SMR Shoulder HP Reverse Glenosphere

L

Limacorporate

Status

Unknown

Conditions

Arthroplasty, Replacement, Shoulder

Treatments

Device: SMR shoulder arthroplasty

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

Study Design: Single arm, retrospective and prospective, single center, post-market clinical study Purpose:To demonstrate the safety and effectiveness of the SMR Reverse HP Shoulder System device for primary, fracture or revision total shoulder replacement out to 24 months. The eligible study population is the entire population that underwent a reverse shoulder arthroplasty performed with 36-mm CoCrMo versus 40-mm cross-linked UHMWPE glenospheres between January 1, 2013 and January 1, 2020 at Wrightington Hospital (UK) in accordance with the indication for use of the product.

Enrollment

140 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patient was treated with the SMR Reverse Shoulder System device (either with 36-mm CoCrMo glenosphere or 40-mm cross-linked UHMWPE glenosphere) between January 1, 2013 and January 1, 2020 as per Instruction for Use
  2. Patient was an adult male or female and was 18 years of age or older at the time of surgery
  3. Patient received the SMR Reverse Shoulder System for primary, fracture, or revision total shoulder replacement in a grossly rotator cuff deficient joint with severe arthroplasty
  4. The patient's joint was anatomically and structurally suited to receive the selected implants, with a functional deltoid muscle
  5. Surgery date is at least 24 months from screening of data
  6. Patient has baseline radiographs and Oxford Shoulder Score

Exclusion criteria

1 Patient was treated with the SMR Reverse Shoulder System device (either with 36-mm CoCrMo glenosphere or 40-mm cross-linked UHMWPE glenosphere) between January 1, 2013 and January 1, 2020 out of the Indications for Use

Trial design

140 participants in 2 patient groups

36 mm CoCrMo glenospheres
Treatment:
Device: SMR shoulder arthroplasty
40 mm cross-linked UHMWPE glenospheres
Treatment:
Device: SMR shoulder arthroplasty

Trial contacts and locations

1

Loading...

Central trial contact

Ilaria Ciani

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems